Treatment of Ren2 with the angiotensin‐type 1 receptor (AT1R) blocker, valsartan has been shown to reduce albuminuria, high blood pressure and increase renal ACE2 and NEP mRNAs expression (Whaley‐Connell et al., 2006). The gene discussed is AGTR1; the disease is hypertensive disorder.